{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T06:34:04Z","timestamp":1794119644802,"version":"4.8.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["psy-journal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.psychres.2016.02.052","type":"journal-article","created":{"date-parts":[[2016,2,24]],"date-time":"2016-02-24T20:12:01Z","timestamp":1456344721000},"page":"85-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"special_numbering":"C","title":["Pro- and anti-inflammatory cytokines, but not CRP, are inversely correlated with severity and symptoms of major depression"],"prefix":"10.1016","volume":"239","author":[{"given":"Frank M.","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth C.","family":"Kirkby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Suslow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesca M.","family":"Holdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Teupser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Hegerl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubertus","family":"Himmerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2016.02.052_bib1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/2150131912454012","article-title":"Patient body Mass index does not predict six-month clinical outcome of depression managed under collaborative care","volume":"4","author":"Angstman","year":"2013","journal-title":"J. Prim. Care Community Health"},{"key":"10.1016\/j.psychres.2016.02.052_bib2","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.biopsych.2012.04.002","article-title":"Tumor necrosis factor gene variation predicts hippocampus volume in healthy individuals","volume":"72","author":"Baune","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2016.02.052_bib3","series-title":"BDI\u2013II, Beck Depression Inventory: Manual","author":"Beck","year":"1996"},{"key":"10.1016\/j.psychres.2016.02.052_bib4","first-page":"200","article-title":"So depression is an inflammatory disease, but where does the inflammation come from? BMC","volume":"11","author":"Berk","year":"2013","journal-title":"Medicine"},{"key":"10.1016\/j.psychres.2016.02.052_bib5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0165-0327(02)00315-4","article-title":"Interleukin-1\u03b2 and tumor necrosis factor-\u03b1in children with major depressive disorder or dysthymia","volume":"78","author":"Brambilla","year":"2004","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2016.02.052_bib6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.psyneuen.2014.03.019","article-title":"The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery","volume":"45","author":"Dahl","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psychres.2016.02.052_bib7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.psychres.2016.02.052_bib8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.iac.2009.02.002","article-title":"Cytokine, sickness behavior, and depression","volume":"29","author":"Dantzer","year":"2009","journal-title":"Immunol. Allergy Clin. N. Am."},{"key":"10.1016\/j.psychres.2016.02.052_bib9","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1210\/endo.138.12.5616","article-title":"Interferon-gamma potentiates interleukin (IL)-6 and tumor necrosis factor-alpha but not IL-1beta induced by endotoxin in the brain","volume":"138","author":"De Simoni","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.psychres.2016.02.052_bib10","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2016.02.052_bib11","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3390\/medicina45120124","article-title":"Soluble interleukin-2 receptor and tumor necrosis factor levels in depressed patients in Estonia","volume":"45","author":"Eller","year":"2009","journal-title":"Medicina"},{"key":"10.1016\/j.psychres.2016.02.052_bib12","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.pnpbp.2007.09.015","article-title":"Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder","volume":"32","author":"Eller","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2016.02.052_bib13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neuroscience.2013.04.060","article-title":"Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications","volume":"246","author":"Felger","year":"2013","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.psychres.2016.02.052_bib14","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1038\/tp.2012.14","article-title":"Reduced expression of glucocorticoid-inducible genes GILZ and SGK-1: high IL-6 levels are associated with reduced hippocampal volumes in major depressive disorder","volume":"13","author":"Frodl","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.psychres.2016.02.052_bib15","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3389\/fnins.2014.00420","article-title":"Influence of sex and stress exposure across the lifespan on endophenotypes of depression: focus on behavior, glucocorticoids, and hippocampus","volume":"8","author":"Gobinath","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.psychres.2016.02.052_bib16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.psychres.2016.02.052_bib17","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1038\/npp.2011.132","article-title":"The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis","volume":"36","author":"Hannestad","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2016.02.052_bib18","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.biopsych.2006.03.075","article-title":"Successful antidepressant therapy restores the disturbed interplay between TNF-alpha system and HPA axis","volume":"60","author":"Himmerich","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2016.02.052_bib19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.eurpsy.2008.03.013","article-title":"Depression, comorbidities and the TNF-alpha system","volume":"23","author":"Himmerich","year":"2008","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.psychres.2016.02.052_bib20","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.jpsychires.2010.03.005","article-title":"Regulatory T cells increased while IL-1\u03b2 decreased during antidepressant therapy","volume":"44","author":"Himmerich","year":"2010","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2016.02.052_bib21","doi-asserted-by":"crossref","first-page":"5958","DOI":"10.2174\/138161212803523653","article-title":"Choice of treatment with antidepressants: influencing factors","volume":"18","author":"Himmerich","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.psychres.2016.02.052_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0893-133X(00)00089-0","article-title":"Effects of antidepressants on weight and on the plasma levels of leptin, TNF-alpha and soluble TNF receptors: a longitudinal study in patients treated with amitriptyline OR paroxetine","volume":"23","author":"Hinze-Selch","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2016.02.052_bib23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.psychres.2016.02.052_bib24","doi-asserted-by":"crossref","unstructured":"Huang, C., Chen, J.H., 2014. Meta-Analysis of the Factor Structures of the Beck Depression Inventory-II. Assessment, pii: 1073191114548873.","DOI":"10.1177\/1073191114548873"},{"key":"10.1016\/j.psychres.2016.02.052_bib25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/hup.1103","article-title":"A psychoneuroimmunological review on cytokines involved in antidepressant treatment response","volume":"25","author":"Janssen","year":"2010","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.psychres.2016.02.052_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2190\/PM.43.1.a","article-title":"Associations between plasma cytokines and depressive mood in patients with breast cancer","volume":"43","author":"Kim","year":"2012","journal-title":"Int. J. Psychiatry Med."},{"key":"10.1016\/j.psychres.2016.02.052_bib27","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1055\/s-2002-36390","article-title":"Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine","volume":"35","author":"Kraus","year":"2002","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.psychres.2016.02.052_bib28","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jpsychires.2013.01.007","article-title":"Antidepressant effects of TNF-\u03b1 blockade in an animal model of depression","volume":"47","author":"Kr\u00fcgel","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2016.02.052_bib29","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0893-133X(99)00134-7","article-title":"Cytokine production and treatment response in major depressive disorder","volume":"22","author":"Lanquillon","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2016.02.052_bib30","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3109\/09540261.2013.813442","article-title":"Cytokines as biomarkers in depressive disorder: current standing and prospects","volume":"25","author":"Lichtblau","year":"2013","journal-title":"Int. Rev. of Psychiatry"},{"key":"10.1016\/j.psychres.2016.02.052_bib31","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pnpbp.2013.05.005","article-title":"Obesity and psychiatric disorders: commonalities in dysregulated biological pathways and their implications for treatment","volume":"45","author":"Lopresti","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2016.02.052_bib32","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1741-7015-10-66","article-title":"Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways","volume":"10","author":"Maes","year":"2012","journal-title":"BMC Med."},{"key":"10.1016\/j.psychres.2016.02.052_bib33","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1006\/cyto.1997.0238","article-title":"Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression","volume":"9","author":"Maes","year":"1997","journal-title":"Cytokine"},{"key":"10.1016\/j.psychres.2016.02.052_bib34","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0165-0327(95)00028-L","article-title":"Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferring receptor in major depression","volume":"34","author":"Maes","year":"1995","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2016.02.052_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11011-008-9118-1","article-title":"The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression","volume":"24","author":"Maes","year":"2009","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.psychres.2016.02.052_bib36","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.3390\/toxins5112227","article-title":"Impact of antidepressants on cytokine production of depressed patients in vitro","volume":"5","author":"Munzer","year":"2013","journal-title":"Toxins"},{"key":"10.1016\/j.psychres.2016.02.052_bib37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00702-014-1328-6","article-title":"Impact of lithium alone and in combination with antidepressants on cytokine production in vitro","volume":"122","author":"Petersein","year":"2015","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.psychres.2016.02.052_bib38","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0306-4530(01)00101-9","article-title":"Endotoxin-induced changes in food consumption in healthy volunteers are associated with TNF \u03b1 and IL-6 secretion","volume":"27","author":"Reichenberg","year":"2002","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psychres.2016.02.052_bib39","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jpsychires.2014.04.021","article-title":"Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity","volume":"55","author":"Schmidt","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2016.02.052_bib40","first-page":"288","article-title":"The TNF-alpha inhibitor etanercept as monotherapy in treatment-resistant depression-report of two cases","volume":"26","author":"Schmidt","year":"2014","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.psychres.2016.02.052_bib41","doi-asserted-by":"crossref","first-page":"e0121971","DOI":"10.1371\/journal.pone.0121971","article-title":"Inflammatory cytokines in general and central obesity and modulating effects of physical activity","volume":"10","author":"Schmidt","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.psychres.2016.02.052_bib42","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jad.2015.03.039","article-title":"Melanin-concentrating Hormone (MCH) in major depressive disorder during antidepressant therapy","volume":"180","author":"Schmidt","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2016.02.052_bib43","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.psychres.2011.11.014","article-title":"Sensitivity to detect change and the correlation of clinical factors with the Hamilton depression rating scale and the beck depression inventory in depressed inpatients","volume":"198","author":"Schneibel","year":"2012","journal-title":"Psychiatry Res."},{"issue":"12","key":"10.1016\/j.psychres.2016.02.052_bib44","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/j.euroneuro.2013.06.002","article-title":"The role of inflammatory cytokines in suicidal behavior: a systematic review","volume":"23","author":"Serafini","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2016.02.052_bib45","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/1099800414543821","article-title":"Relationships among prenatal depression, plasma cortisol, and inflammatory cytokines","volume":"17","author":"Shelton","year":"2015","journal-title":"Biol. Res. for. Nursing"},{"key":"10.1016\/j.psychres.2016.02.052_bib46","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.euroneuro.2007.06.004","article-title":"A detailed examination of cytokine abnormalities in major depressive disorder","volume":"18","author":"Simon","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2016.02.052_bib47","doi-asserted-by":"crossref","first-page":"e102692","DOI":"10.1371\/journal.pone.0102692","article-title":"Insular and hippocampal gray matter volume reductions in patients with major depressive disorder","volume":"9","author":"Stratmann","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.psychres.2016.02.052_bib48","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.arr.2005.03.003","article-title":"The stress system in the human brain in depression and neurodegeneration","volume":"4","author":"Swaab","year":"2005","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.psychres.2016.02.052_bib49","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1176\/appi.ajp.162.1.175","article-title":"Increase in interleukin-1beta in late-life depression","volume":"162","author":"Thomas","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2016.02.052_bib50","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/PSY.0000000000000000","article-title":"Relationship between obesity and depression: characteristics and treatment outcomes with antidepressant medication","volume":"75","author":"Toups","year":"2013","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.psychres.2016.02.052_bib51","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(05)67763-X","article-title":"Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial","volume":"367","author":"Tyring","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2016.02.052_bib52","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1176\/appi.ajp.2014.14010094","article-title":"An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline","volume":"171","author":"Uher","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2016.02.052_bib53","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/archpsyc.1988.01800320058007","article-title":"A structured interview guide for the Hamilton depression rating scale","volume":"45","author":"Williams","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2016.02.052_bib54","unstructured":"Wittchen, H.U., Zaudig, M., Fydrich, T., 1997. SKID Strukturiertes Klinisches Interview f\u00fcr DSM-IV (Achse I und II). Hogrefe, G\u00f6ttingen."},{"key":"10.1016\/j.psychres.2016.02.052_bib55","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1158\/1055-9965.EPI-08-0311","article-title":"Reproducibility and correlations of multiplex cytokine levels in asymptomatic persons","volume":"17","author":"Wong","year":"2008","journal-title":"Cancer Epidemiol Biomark. Prev."},{"key":"10.1016\/j.psychres.2016.02.052_bib56","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.pnpbp.2009.03.020","article-title":"Higher plasma interleukin-6 (IL-6) level is associated with SSRI- OR SNRI-refractory depression","volume":"33","author":"Yoshimura","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178116303304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178116303304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,5]],"date-time":"2022-06-05T01:58:36Z","timestamp":1654394316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178116303304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":56,"alternative-id":["S0165178116303304"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2016.02.052","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pro- and anti-inflammatory cytokines, but not CRP, are inversely correlated with severity and symptoms of major depression","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2016.02.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}